Hippocratic AI has a deliberately narrow pitch, and that is the whole point. It builds AI agents that call patients on the phone for routine, non-diagnostic stuff, like checking on meds or following up after a hospital stay. It will not diagnose you, on purpose, because founder Munjal Shah decided the safest way into healthcare is to avoid the risky parts. Investors bought it hard, valuing the company at $1.64 billion in a January 2025 round led by Kleiner Perkins. Nvidia is a backer and a partner, because making an AI sound human on a phone call is a genuinely hard problem.
Founded
2023
HQ
Palo Alto, USA
Total Raised
$278 million
Founder
Munjal Shah
Status
Private
Website
www.hippocraticai.comTHE ORIGIN STORY
Munjal Shah is a repeat founder. He built Like.com, a visual shopping search engine that Google bought in 2010.
He later founded Health IQ, an insurance company for health-conscious people. In 2023 he started Hippocratic AI with a team of doctors, hospital leaders, and AI researchers pulled from places like Stanford, Johns Hopkins, Microsoft, Google, and Nvidia.
The founding idea was contrarian for the AI hype cycle. Instead of racing to build an AI doctor, Shah decided to build an AI that does the safe, non-diagnostic work, the phone calls and check-ins that eat up nurses' time.
WHAT THEY ACTUALLY DO
Here is the simple version. Hospitals and health systems are short on nurses and staff.
A huge amount of care is really just talking to patients, reminding them to take medicine, checking how they feel after surgery, prepping them for a procedure. Hippocratic AI builds AI agents that make those calls.
It charges by the hour, priced well below what a human clinician costs. Health systems pay for the agents, patients get more frequent check-ins, and the nurses get freed up for the work that actually needs a human.
THE PRODUCTS
The main product is a fleet of AI healthcare agents built on Hippocratic AI's own safety-focused large language model. The company's Polaris system runs the real-time phone conversations.
The agents handle things like chronic care check-ins, medication reminders, post-discharge follow-up, and pre-op preparation. Each one is aimed at a specific non-diagnostic job.
The pitch is that they perform these tasks at a level the company says matches human clinicians on safety, while being available around the clock.
HOW THEY GREW
The clever bit is the safety framing. Healthcare is terrified of AI making a deadly mistake, so Hippocratic AI ruled out diagnosis entirely and put safety at the center of its whole story.
That made cautious hospital buyers comfortable enough to try it. The company moved fast on proof, signing contracts with 23 health systems, payers, and pharma clients within its first stretch.
It also teamed up with Nvidia to make the agents respond in real time, because an AI that pauses awkwardly on a call feels wrong to a patient. Trust plus speed is the growth engine.
THE HARD PART
The core challenge is that healthcare does not forgive mistakes. Even non-diagnostic calls can go wrong if the AI says the wrong thing to a sick, scared person.
One bad, public failure could set the whole company back. There is also the question of whether patients actually want to talk to a bot about their health, and whether nurses' unions and regulators push back.
And the valuation is steep at $1.64 billion for a company only founded in 2023. Hippocratic AI has to prove its agents are as safe as it claims, at massive scale, before something breaks.
MONEY TRAIL
Seed
2023 · Led by General Catalyst
$50M raised
Series A
2024 · Led by Premji Invest
$53M raised
$500M valuation
Series B
2025 · Led by Kleiner Perkins
$141M raised
$1.6B valuation
WHO BACKED THEM
The backers are heavy hitters. The 2023 seed round of $50 million was co-led by General Catalyst and Andreessen Horowitz.
Premji Invest and General Catalyst led the Series A in 2024. Kleiner Perkins led the $141 million Series B in January 2025 that valued the company at $1.64 billion.
Nvidia's venture arm is in too, which matters because Hippocratic AI runs on Nvidia's technology for its voice agents. Several hospital systems have also invested, betting on a tool they might use themselves.
Related Profiles
Head-to-Head
Compare Hippocratic AI vs another company.